Dividend Aristocrats

No changes this month. The portfolio already holds 7 quality dividend names (JNJ, PG, KO, ADP, CL, MCD, XOM) with weights all between about 11.5% and 18.2% - well within the 6-8 name target and under the 20% single-position cap. A review of recent news found no deterioration in dividend safety anywhere in the book: JNJ just logged its 64th consecutive annual dividend increase and its recent 'earnings guidance cut' is purely an accounting effect of two biotech deals, not a sign of business weakness. PG just delivered its 70th straight annual dividend hike, and Colgate continues its own multi-decade raise streak. XOM's shares actually rose this week on strong Q2 earnings and record production, reinforcing rather than threatening its payout. Since the strategy calls for trading infrequently and selling only when dividend safety deteriorates, and nothing here shows that, the best action is to hold the current allocation unchanged.

Starting from an all-cash portfolio, I built a 7-name basket of blue-chip dividend payers, sized so quality names get the biggest checks and no single stock exceeds 20% of the portfolio. Johnson & Johnson gets the top slot (19%) because it holds one of only two AAA credit ratings in corporate America, has a moderate payout ratio around 50-60% of free cash flow, and just extended its dividend-increase streak to 64 years - about as safe as dividend income gets. Procter & Gamble (17%) and Coca-Cola (15%) follow as classic, financially conservative dividend growers with long track records and manageable payout levels. ADP (14%) is a financially strong payroll/HR processor with steady cash generation and a consistent dividend growth history. Colgate-Palmolive (12%) is a 64-year Dividend King whose payout is comfortably funded by its roughly $3.6 billion in free cash flow, even though some payout-ratio metrics look stretched depending on methodology. McDonald's (12%) earns a spot on the strength of its franchise-royalty cash flow model, even though its stock has lagged over the past few months. Exxon Mobil (11%) rounds out the book as a lower-weighted, more cyclical holding included for diversification, given its historically low payout ratio and long dividend-growth record, even though energy names carry more commodity-price risk. I deliberately left out three names from the universe: 3M was excluded because it slashed its dividend by more than half in 2024 as part of the Solventum spinoff and still carries legacy PFAS/earplug litigation risk, breaking the 'consistent growth' criterion even though its payout ratio now looks safer. PepsiCo was excluded despite its 54-year increase streak because its payout ratio has been running near 86-88% of earnings, well above what I consider a comfortable safety margin, compounded by ongoing activist-investor pressure from Elliott Management that adds uncertainty to capital allocation. Kimberly-Clark was excluded because its payout ratio has climbed to roughly 79-80%, with free cash flow only barely covering the dividend in recent quarters - a yield that looks attractive on paper but comes with less cushion than the other names here. This is a starting allocation; per the strategy, I'll trade infrequently and will only trim or exit positions if payout ratios or cash-flow coverage deteriorate materially.